Susi Teichmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Susi Teichmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Susi Teichmann Today - Breaking & Trending Today

Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID

Published: December 8, 2021

DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group than the vancomycin group

Source: finanznachrichten.de

Related Topics:

United StatesUnited KingdomMark WilcoxKostenloser WertpapierhandelVan PrehnSusi TeichmannTillotts PharmaAdrian HillAntimicrob ChemotherJapanese Zeria GroupClinical Study GroupSociety For Healthcare Epidemiology Of AmericaInfectious Disease Society Of AmericaLeeds Teaching Hospitals University OfHead Of International OperationsCorporate CommunicationsEuropean Society Of Clinical MicrobiologyEuropean Centre For Disease PreventionFirst Section Of Tokyo Stock ExchangeInfectious Diseases Society Of AmericaZeria Pharmaceutical Co LtdEuropean SocietyClinical MicrobiologyInfectious DiseasesInfectious Disease Society